Denosumab versus placebo as adjuvant treatment for women with early-stage breast cancer at high risk of disease recurrence (D-CARE): An international, placebo-controlled, randomized, double-blind phase III clinical trial.

被引：0
|
作者：
Goss, Paul E.
Barrios, Carlos H.
Chan, Arlene
Finkelstein, Dianne M.
Iwata, Hiroji
Martin, Miguel
Braun, Ada
Ding, Beiying
Maniar, Tapan
Coleman, Robert E.
机构：
[1] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
[2] PUCRS Sch Med, Porto Alegre, RS, Brazil
[3] Curtin Univ, Mt Hosp, Perth, WA 6845, Australia
[4] Aichi Canc Ctr Hosp, Dept Breast Oncol, Nagoya, Aichi 464, Japan
[5] Univ Complutense, Inst Invest Sanitaria Gregario Maranon, E-28040 Madrid, Spain
[6] Amgen Inc, Thousand Oaks, CA 91320 USA
[7] YCR Sheffield Canc Res Ctr, Canc Res UK Inst Canc Studies, Sheffield, S Yorkshire, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS662
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Oral Zinc Sulfate as Adjuvant Treatment in Children With Nephrolithiasis: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial
    Yousefichaijan, Parsa
    Cyrus, Ali
    Dorreh, Fatemeh
    Rafeie, Mohammad
    Sharafkhah, Mojtaba
    Frohar, Faryar
    Safi, Fatemeh
    IRANIAN JOURNAL OF PEDIATRICS, 2015, 25 (06)
  • [32] Cinnamomum tamala as an adjuvant therapy in the treatment of major depressive disorder: A double-blind, randomized, placebo-controlled clinical trial with placebo control
    Ghaffari, Salomeh
    Ghobadi, Ali
    Jamshidi, Amir Hossein
    Mortazavi, Seyyed Hosein
    Naderi, Sina
    Aqamolaei, Ali
    Mortezaei, Amirhosein
    Sahebolzamani, Erfan
    Shamabadi, Ahmad
    Jalilvand, Shakiba
    Daraei, Bahram
    Shalbafan, Mohammad Reza
    Akhondzadeh, Shahin
    ADVANCES IN INTEGRATIVE MEDICINE, 2020, 7 (03) : 141 - 147
  • [33] Zishenpingchan granules for the treatment of Parkinson's disease:a randomized,double-blind,placebo-controlled clinical trial
    Qing Ye
    Xiao-Lei Yuan
    Can-Xing Yuan
    Hong-Zhi Zhang
    Xu-Ming Yang
    Neural Regeneration Research, 2018, (07) : 1269 - 1275
  • [34] Cannabidiol as a Treatment for Neurobiological, Behavioral, and Psychological Symptoms in Early-Stage Dementia: A Double-Blind, Placebo-Controlled Clinical Trial Protocol
    Bartschi, Jessica G.
    Greenwood, Lisa-Marie
    Montgomery, Amy
    Dortants, Lon
    Weston-Green, Katrina
    Huang, Xu-Feng
    Pai, Nagesh
    Potter, Jan
    Schira, Mark M.
    Croft, Rodney
    Solowij, Nadia
    CANNABIS AND CANNABINOID RESEARCH, 2023, 8 (02) : 348 - 359
  • [35] Zishenpingchan granules for the treatment of Parkinson's disease: a randomized, double-blind, placebo-controlled clinical trial
    Ye, Qing
    Yuan, Xiao-Lei
    Yuan, Can-Xing
    Zhang, Hong-Zhi
    Yang, Xu-Ming
    NEURAL REGENERATION RESEARCH, 2018, 13 (07) : 1269 - 1275
  • [36] Oxymetholone for the treatment of HIV-wasting: A double-blind, randomized, placebo-controlled phase III trial in eugonadal men and women
    Hengge, UR
    Stocks, K
    Faulkner, S
    Wiehler, H
    Lorenz, C
    Jentzen, W
    Hengge, D
    Ringham, G
    HIV CLINICAL TRIALS, 2003, 4 (03): : 150 - 163
  • [37] The CLL12 trial protocol: a placebo-controlled double-blind Phase III study of ibrutinib in the treatment of early-stage chronic lymphocytic leukemia patients with risk of early disease progression
    Langerbeins, Petra
    Bahlo, Jasmin
    Rhein, Christina
    Cramer, Paula
    Pflug, Natali
    Fischer, Kirsten
    Stilgenbauer, Stephan
    Kreuzer, Karl Anton
    Wendtner, Clemens-Martin
    Eichhorst, Barbara
    Hallek, Michael
    FUTURE ONCOLOGY, 2015, 11 (13) : 1895 - 1903
  • [38] Zopiclone versus placebo for short-term treatment of insomnia in patients with advanced cancer—a double-blind, randomized placebo-controlled clinical multicenter phase IV trial
    Gunnhild Jakobsen
    Karin Sjue
    Ørnulf Paulsen
    Stein Kaasa
    Marianne Jensen Hjermstad
    Pål Klepstad
    Supportive Care in Cancer, 2023, 31
  • [39] A randomized, multicenter, double-blind, placebo-controlled comparison of standard (neo)adjuvant therapy plus placebo versus standard (neo)adjuvant therapy plus atorvastatin in patients with early stage breast cancer
    Borgquist, Signe
    Jensen, Maj-Britt
    Ewertz, Marianne
    Jensen, Anders Bonde
    Ahern, Thomas P.
    Cronin-Fenton, Deirdre
    Christiansen, Peer
    Ejlertsen, Bent
    CANCER RESEARCH, 2020, 80 (04)
  • [40] Rasagiline in Chinese Patients with Early-stage Parkinson's Disease: A Randomized, Double-blind, Placebo-controlled, Delayed-start Trial
    Su, W.
    Liu, H. J.
    Wang, L. J.
    Ye, Q. Y.
    Cao, L.
    Zhou, H. Y.
    Luo, X. G.
    Ding, Z. T.
    Wang, T.
    Wang, Q.
    Ma, H. Z.
    Xu, E. H.
    Chen, H. B.
    MOVEMENT DISORDERS, 2023, 38 : S52 - S53
12345